Search results
CNBC's Inside India newsletter: IPO boom looks to break new records
CNBC· 5 days agoThis report is from this week's CNBC's "Inside India" newsletter which brings you timely, insightful...
Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below 200 Day Moving Average of $2.52
ETF DAILY NEWS· 6 days agoPredictive Oncology Inc. (NASDAQ:POAI – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.52 ...
Will the Fed Slow Down Extremely Lopsided Market Strength or Accelerate It?
TheStreet.com· 7 days agoThe market loves to love the Fed, and that tends to favor the Magnificent Seven names. The primary...
Christie Group (LON:CTG) Receives “House Stock” Rating from Shore Capital
ETF DAILY NEWS· 6 days agoChristie Group (LON:CTG – Get Free Report)‘s stock had its “house stock” rating reiterated by Shore Capital in a note issued to investors on Thursday, Digital ...
Destiny Pharma (LON:DEST) Stock Price Up 15.9%
ETF DAILY NEWS· 6 days agoDestiny Pharma plc (LON:DEST – Get Free Report)’s share price rose 15.9% on Tuesday . The stock traded as high as GBX 18.51 ($0.24) and last traded at GBX 18.11 ($0.23). Approximately ...
Bayesian Capital Management LP Makes New Investment in Wells Fargo & Company (NYSE:WFC)
ETF DAILY NEWS· 6 days agoBayesian Capital Management LP acquired a new stake in shares of Wells Fargo & Company (NYSE:WFC –...
First Guaranty Bancshares (NASDAQ:FGBI) Shares Cross Below 50-Day Moving Average of $10.57
ETF DAILY NEWS· 6 days agoFirst Guaranty Bancshares, Inc. (NASDAQ:FGBI – Get Free Report)’s share price crossed below its...
As European Bonds Get Spooked, Treasuries Could Get a Boost
TheStreet.com· 1 day agoElections in France seem to have finally spooked European bonds. This jolt appears to go beyond...
Nabriva Therapeutics (NASDAQ:NBRV) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Free Report) in a research note published on Wednesday. The brokerage issued a hold rating on the biotechnology ...
Q4 2026 Earnings Estimate for Haemonetics Co. (NYSE:HAE) Issued By Zacks Research
ETF DAILY NEWS· 6 days agoZacks Research analyst R. Department now expects that the medical instruments supplier will earn $1.31 per share for the quarter, up from their previous forecast of $1.30. The consensus estimate ...